Neoadjuvant letrozole-palbociclib combo might allow sparing chemotherapy in high-risk ER+/HER2- early breast cancerApril 25, 2022Breast Cancer
Trastuzumab deruxtecan bests trastuzumab emtansine in HER2+ metastatic breast cancerApril 25, 2022Breast Cancer
Oncology PracticeThree in four U.S. doctors are employed by hospitals, corporate entities: ReportApril 25, 2022Business of MedicinePractice Management
Oncology PracticeAge, skin cancer risks for ICI-induced bullous pemphigoid identifiedApril 22, 2022MelanomaPatient & Survivor CareImmuno-oncologyImmunotherapy
Hematology NewsCancer hospitals often mark up drug prices, ignore price transparency rulesApril 22, 2022Practice ManagementBusiness of Medicine
Oncology PracticePreop nivolumab plus chemo ‘a quantum leap’ in NSCLC therapyApril 22, 2022Lung Cancer
Oncology PracticeRecurrent DCIS can be genetically distinct from primary lesionApril 22, 2022Breast Cancer
Hematology NewsDoc accused of killing 14 patients found not guiltyApril 21, 2022Patient & Survivor Care
Oncology PracticeWhich breast cancer surgery leads to better quality of life?April 21, 2022Breast Cancer
